Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Hexavalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women
Condition: Group B Streptococcus Infections Interventions: Biological: Hexavalent Group B streptococcus vaccine; Biological: Tetanus, diphtheria, and acellular pertussis vaccine; Biological: Placebo Sponsor: Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials